In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response

Author(s):
Moel, E.C. de; Derksen, V.F.A.M.; Trouw, L.A. (0000-0001-5186-2290); Bang, H.; Collee, G.; Lard, L.R.; Ramiro, S.; Huizinga, T.W.J. (0000-0001-7033-7520); Allaart, C.F.; Toes, R.E.M. (0000-0002-9618-6414); Woude, D. van der (0000-0001-8121-5879)
Published
2019
Publication type
Article / Letter to editor
Rheumatoid arthritisAutoantibodiesAnt-CCP2Rheumatoid factorAnti-carbamylated protein antibodiesDisease activityImmunosuppression
Date issued
2019-01-18
Language
English
Is part of
Arthritis Research and Therapy
hdl
1887/119663
doi
10.1186/s13075-019-1815-0